HPV integration status conversion and CIN2 + cancer risk stratification based on HPV integration levels among HPV integration-positive women: a 1-year follow-up study
Kexin Li, Fanwei Huang, Tao Zhang, Fan Yang, Weitao Duan, Shimin Chen, Ting Hu, Xiaoyuan Huang
Springer Nature ·
2025-05-19
· DOI 10.1186/s12885-025-14138-4
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Kexin Li, Fanwei Huang, Tao Zhang, Fan Yang, Weitao Duan, Shimin Chen et al. HPV integration status conversion and CIN2 + cancer risk stratification based on HPV integration levels among HPV integration-positive women: a 1-year follow-up study. // BMC Cancer. – 2025. – DOI: 10.1186/s12885-025-14138-4. – URL: https://doi.org/10.1186/s12885-025-14138-4
Kexin Li, Fanwei Huang, Tao Zhang, Fan Yang, Weitao Duan, Shimin Chen, Ting Hu, & Xiaoyuan Huang (2025). HPV integration status conversion and CIN2 + cancer risk stratification based on HPV integration levels among HPV integration-positive women: a 1-year follow-up study. BMC Cancer. https://doi.org/10.1186/s12885-025-14138-4
Kexin Li, et al. “HPV integration status conversion and CIN2 + cancer risk stratification based on HPV integration levels among HPV integration-positive women: a 1-year follow-up study.” BMC Cancer, 2025. doi:10.1186/s12885-025-14138-4.
@article{Li2025,
title = {HPV integration status conversion and CIN2 + cancer risk stratification based on HPV integration levels among HPV integration-positive women: a 1-year follow-up study},
author = {Li, Kexin and Huang, Fanwei and Zhang, Tao and Yang, Fan and Duan, Weitao and Chen, Shimin and Hu, Ting and Huang, Xiaoyuan},
journal = {BMC Cancer},
year = {2025},
doi = {10.1186/s12885-025-14138-4},
url = {https://doi.org/10.1186/s12885-025-14138-4}
}